Poly(DL-Lactide-Co-Glycolide) structure
|
Common Name | Poly(DL-Lactide-Co-Glycolide) | ||
---|---|---|---|---|
CAS Number | 26780-50-7 | Molecular Weight | 148.11400 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C5H8O5 | Melting Point | N/A | |
MSDS | USA | Flash Point | 113℃ |
Name | poly(DL-lactic acid-co-glycolic acid) |
---|---|
Synonym | More Synonyms |
Molecular Formula | C5H8O5 |
---|---|
Molecular Weight | 148.11400 |
Flash Point | 113℃ |
Exact Mass | 148.03700 |
PSA | 83.83000 |
Appearance of Characters | Crystalline Powder or Granules | White to tan |
Storage condition | −20°C |
Water Solubility | ethyl acetate, chloroform, acetone and THF: soluble |
Hazard Codes | Xi |
---|---|
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
Simple measurements for prediction of drug release from polymer matrices - Solubility parameters and intrinsic viscosity.
Eur. J. Pharm. Biopharm. 92 , 1-7, (2015) This study describes how protein release from polymer matrices correlate with simple measurements on the intrinsic viscosity of the polymer solutions used for casting the matrices and calculations of ... |
|
Induction of long-lasting protective immunity against Toxoplasma gondii in BALB/c mice by recombinant surface antigen 1 protein encapsulated in poly (lactide-co-glycolide) microparticles.
Parasit. Vectors 6 , 34, (2013) Current development efforts of subunit vaccines against Toxoplasma gondii, the etiological agent of toxoplasmosis, have been focused mainly on tachyzoite surface antigen 1 (SAG1). Since microparticles... |
|
Reduced postoperative chronic pain after tension-free inguinal hernia repair using absorbable sutures: a single-blind randomized clinical trial.
J. Am. Coll. Surg. 218(1) , 102-7, (2014) Chronic pain after inguinal hernia repair occurs in 16% to 62% of patients. The underlying mechanism probably involves sensory nerve damage and abnormal healing that might be influenced by the materia... |
MFCD00131930 |
Poly(DL-Lactide-Co-Glycolide) |